This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignee: Johns Hopkins University. Active years: 2009-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2016
Title: Anssi Jussi Nikolai Taipale: Innovator in Hedgehog Pathway Research
Introduction
Anssi Jussi Nikolai Taipale is a prominent inventor based in Espoo, Finland. He has made significant contributions to the field of molecular biology, particularly in the study of the hedgehog signaling pathway. With a total of 5 patents to his name, Taipale's work has implications for understanding various biological processes and potential therapeutic applications.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Regulators of the hedgehog pathway, compositions and uses related thereto." This invention provides methods and reagents for modulating smoothened-dependent pathway activation. The subject methods can be utilized to counteract the phenotypic effects of unwanted activation of the hedgehog pathway, which may arise from mutations such as hedgehog gain-of-function, ptc loss-of-function, or smoothened gain-of-function.
Career Highlights
Taipale is affiliated with Johns Hopkins University, where he continues to advance research in his field. His innovative approaches have garnered attention and respect within the scientific community. His work not only contributes to academic knowledge but also has the potential to influence therapeutic strategies in medicine.
Collaborations
Throughout his career, Taipale has collaborated with notable scientists, including Philip Arden Beachy and James K Chen. These collaborations have further enriched his research and expanded the impact of his inventions.
Conclusion
Anssi Jussi Nikolai Taipale is a distinguished inventor whose work on the hedgehog pathway has opened new avenues for research and potential medical applications. His contributions continue to shape the landscape of molecular biology and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
